Matching slides 26,550
Current window 20,491-20,520
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all

Arc

20,491-20,520 of 26,550

filter-aware
13
The slide uses a visual process flow to explain the mechanism of action.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Includes clinical trial abbreviations and source citation in footer.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide appears to be a template or placeholder with only the title present.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide outlines a clinical trial protocol for Itolizumab in patients with active proliferative lupus nephritis (apLN).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Data includes age, gender, race, country, disease duration, treatment history, LN class, and renal function metrics.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
Data cut-off date: September 2, 2022.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a structured table-like layout to categorize safety findings.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The chart shows concentration over time for different dosage groups (0.4 to 3.2 mg/kg) for Type A and Type B subjects.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The chart uses stacked bars to visualize the breakdown of Complete Response (two categories), Partial Response, and No Response.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
27
The chart tracks subject progress over time (weeks) with markers for treatment milestones and clinical responses.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
28
The chart uses a waterfall-style visualization to show individual subject outcomes relative to a 50% reduction threshold.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
29
The chart includes error bars representing standard error (SE) and sample sizes (n) at each time point.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
30
The table compares interim analysis data for Itolizumab against historical AMP SoC data across 3, 6, and 12-month intervals.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
31
Slide 31 of a presentation deck.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a numbered list format to categorize six distinct macro issues, each paired with a supporting news clipping.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
Uses a visual legend to represent degrees of applicability.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
Uses a causal chain/equation format to explain the business model transformation.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
11
Uses a standard concentric circle diagram to represent market sizing.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
12
The slide uses a hierarchical structure to connect high-level corporate identity to operational differentiators.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
13
The slide uses a hub-and-spoke diagram to illustrate four core ESG pillars surrounding a central commitment statement.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
14
The slide uses product imagery as the primary vehicle for communicating value propositions.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
15
The map highlights a concentration of sites in North America within a dashed circle.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
16
The slide uses a value chain framework to map technology capabilities from seed to sale.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
17
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit